Family PracticeNursingOBGYN & Women's HealthPediatricsPulmonologyInternal MedicineCritical CareEmergency MedicinePathologyPharmacyCenters For Disease ControlPublic HealthVaccinesInfectious DiseaseCoronavirus
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
WEDNESDAY, Sept. 2, 2020 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention is telling the nation to prepare for distribution of a COVID-19 vaccine this fall.
The CDC has notified public health officials across all 50 states that limited vaccine doses might be available by late October, and that they should prepare now as to how the vaccine will be routed to health care workers and other high-risk groups, according to documents obtained by The New York Times. The documents outline detailed scenarios for distributing two unnamed vaccines -- "Vaccine A" and "Vaccine B" -- if either or both candidates demonstrate sufficient effectiveness and safety to warrant an emergency use authorization from the CDC before clinical trials are fully completed.
The CDC documents recommend that the vaccine first be given to health care professionals and essential workers, followed by people involved in national security and individuals living or working in long-term care facilities. People aged 65 or older, those at increased risk for severe illness, people attending colleges or universities, and Americans serving time in prison or living in homeless shelters are also earmarked as critical populations that should receive early vaccination.
States should plan now for real-time shipment of the vaccine, which would be free but potentially subject to some administration fees, the documents noted. People will likely need two doses of the vaccine, given three to four weeks apart, to achieve immunity, the agency said. The documents also put forth a schedule of assumed availability of both vaccine candidates, should either qualify for emergency use: Vaccine A could have around 2 million doses available by the end of October and as many as 30 million by year's end; Vaccine B could have around 1 million doses available by the end of October and as many as 15 million by the end of the year.
The three documents went out on Aug. 27 to all 50 states as well as New York, Chicago, Philadelphia, Houston, and San Antonio, The Times reported.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at firstname.lastname@example.org with any questions.
Updated on May 25, 2022
Read this Next
Other Trending Articles